N/A
N=62
Iterative Beta Testing of Videos for the DIPPer Academy
Type1diabetes
Bottom Line
View on ClinicalTrials.gov: NCT03385265 ↗Enrolled (actual)
62
Serious AEs
0.0%
Results posted
Mar 2022
Primary outcome: Primary: Child Glycemic Control — 7.56; 8.14 percentage of glycated hemoglobin cells
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- DIPPer Academy (Behavioral); Standard of Care (Other)
- Age
- Pediatric, Adult, Older Adult · 3+ yrs
- Sex
- All
- Sponsor
- University of Kansas Medical Center
- Primary completion
- Jul 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Child Glycemic Control |
7.56; 8.14 | — |
| PRIMARY Parent Depressive Symptoms |
10.0; 7.33 | — |
| PRIMARY Parent Diabetes Distress |
29.23; 27.36 | — |
| SECONDARY Family Mealtime behaviors_Frequency |
78.23; 92.67 | — |
| SECONDARY Parents' Hypoglycemia Fear |
71.08; 64.00 | — |
| SECONDARY Parenting Stress- Frequency |
95.77; 90.44 | <0.05 sig |
| SECONDARY Parents' T1D Self-efficacy |
34.62; 33.67 | — |
| SECONDARY Parent Knowledge of T1D |
98.94; 97.70 | — |
| SECONDARY Behavioral Pediatric Feeding Assessment Scale_Problem |
2.15; 7.18 | — |
Summary
The purpose of this research is to develop DIPPer Academy, a parent-focused, mobile health (mHealth) behavioral intervention to promote glycemic control in young children.
Eligibility Criteria
Inclusion Criteria
- Parents of a young child who is between 3-5.99 years old and at least 6 months post T1D diagnosis
- Parents who are English-speaking.
Exclusion Criteria
- Parents of young children with evidence of type 2 diabetes or monogenic diabetes.
- Parents with evidence of severe psychiatric disorder.
- Parents of young children with a comorbid chronic illness (e.g., renal disease) that requires ongoing care beyond T1D.
- Parents of young children with a history of anemia or medication use that may interact with glycemic control (e.g., systemic steroids).
Data sourced from ClinicalTrials.gov (NCT03385265). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.